最新报道:BIO token plunged 189.98% within 24 hours as regulatory pressures and market instability intensified. Key industry players are calling for more transparent regulatory frameworks to maintain equilibrium between innovation and compliance. Analysts note the dramatic price decline signals investors shifting toward stable assets rather than fundamental value changes in the project. While short-term volatility persists, experts emphasize BIO's long-term growth prospects still hinge on achieving clearer policy guidance from regulators.